The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,593
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,588
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez, D. E., Alonso, D. F., Yoshiji, H., & Thorgeirsson, U. P. (1997) · PubMed · Cited by 1,508
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Matrix metalloproteinases in tumour invasion and metastasis
Curran, S., & Murray, G. I. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199911)189:3<300::aid-path456>3.0.co;2-c · Cited by 661
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
Patterson, B. C., & Sang, Q. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28823 · Cited by 433
Kähäri, V.-M., & Saarialho-Kere, U. (1999) · Annals of Medicine · doi:10.3109/07853899909019260 · Cited by 408
Kallakury, B., Karikehalli, S., Haholu, A., Sheehan, C. E., Azumi, N., & Ross, J. S. (2001) · PubMed · Cited by 280
Lamoreaux, W. J., Fitzgerald, M. E. C., Reiner, A., Hasty, K. A., & Charles, S. T. (1998) · Microvascular Research · doi:10.1006/mvre.1997.2056 · Cited by 278
Mohan, R., Sivak, J., Ashton, P., Russo, L. A., Pham, B. Q., Kasahara, N., Raizman, M. B., & Fini, M. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10405 · Cited by 274
Valente, P., Fassina, G., Melchiori, A., Masiello, L., Cilli, M., Vacca, A., Onisto, M., Santi, L., Stetler-Stevenson, W. G., & Albini, A. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980119)75:2<246::aid-ijc13>3.0.co;2-b · Cited by 273
O'Reilly, M. S., Wiederschain, D., Stetler-Stevenson, W. G., Folkman, J., & Moses, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29568 · Cited by 272
Brown, P. D. N., Bloxidge, R. E., Stuart, N. S. A., Galler, K. C., & Carmichael, J. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.7.574 · Cited by 268
Scorilas, A., Karameris, A., Arnogiannaki, N., Ardavanis, A., Bassilopoulos, P., Trangas, T., & Talieri, M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1810 · Cited by 258
Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.
Rao, J. S., Steck, P. A., Mohanam, S., Stetler‐Stevenson, W. G., Liotta, L. A., & Sawaya, R. A. (1993) · PubMed · Cited by 255
Mirza, A. N., Mirza, N. Q., Vlastos, G., & Singletary, S. E. (2002) · Annals of Surgery · doi:10.1097/00000658-200201000-00003 · Cited by 246
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas
Nakano, A., Tani, E., Miyazaki, K., Yamamoto, Y., & Furuyama, J.-I. (1995) · Journal of Neurosurgery · doi:10.3171/jns.1995.83.2.0298 · Cited by 229
Chirvi, R. G. S., Garofalo, A., Crimmin, M. J., Bawden, L. J., Stoppacciaro, A., Brown, P. D., & Giavazzi, R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580326 · Cited by 219
Matrix metalloproteinase-2 immunoreactive protein: A marker of aggressiveness in breast carcinoma
Talvensaari-Mattila, A., P��kk�, P., H�yhty�, M., Blanco-Sequeiros, G., & Turpeenniemi-Hujanen, T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980915)83:6<1153::aid-cncr14>3.0.co;2-4 · Cited by 217
Self-citationMatrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
Talvensaari-Mattila, A., Pääkkö, P., & Turpeenniemi-Hujanen, T. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601238 · Cited by 217
Self-citationNakagawa, T., Kubota, T., Kabuto, M., Sato, K., Kawano, H., Hayakawa, T., & Okada, Y. (1994) · Journal of Neurosurgery · doi:10.3171/jns.1994.81.1.0069 · Cited by 215
Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo
Sawaya, R. E., Yamamoto, M., Gokaslan, Z. L., Wang, S. W., Mohanam, S., Fuller, G. N., McCutcheon, I. E., Stetler-Stevenson, W. G., Nicolson, G. L., & Rao, J. S. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00157684 · Cited by 197
Cox, G., Jones, J. L., & O'Byrne, K. J. (2000) · PubMed · Cited by 197
Bramhall, S. R., Neoptolemos, J. P., Stamp, G., & Lemoine, N. R. (1997) · The Journal of Pathology · Cited by 192
Kanayama, H., Yokota, K., Kurokawa, Y., Murakami, Y., Nishitani, M., & Kagawa, S. (1998) · Cancer · Cited by 187
Ree, A. H., Flørenes, V. A., Berg, J. P., Mælandsmo, G. M., Nesland, J. M., & Fodstad, Ø. (1997) · PubMed · Cited by 185
Davidson, B., Goldberg, I., Gotlieb, W. H., Kopolovic, J., Ben-Baruch, G., Nesland, J. M., Berner, A., Bryne, M., & Reich, R. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006723011835 · Cited by 183
Grignon, D. J., Sakr, W., Tóth, M., Ravery, V. V., Angulo, J. C., Shamsa, F. H., Pontes, J. E., Crissman, J. C., & Fridman, R. (1996) · PubMed · Cited by 182
Mach, F., Schönbeck, U., Fabunmi, R. P., Murphy, C., Atkinson, E., Bonnefoy, J.-Y., Graber, P., & Libby, P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65269-8 · Cited by 175
Ylisirniö, S., Höyhtyä, M., & Turpeenniemi-Hujanen, T. M. (2000) · PubMed · Cited by 171
Self-citationExpression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas
Rao, J. S., Yamamoto, M., Mohaman, S., Gokaslan, Z. L., Fuller, G. N., Stetler-Stevenson, W. G., Rao, V. H., Liotta, L. A., Nicolson, G. L., & Sawaya, R. E. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00157681 · Cited by 169
Expression and activity of MMPS and their regulators in ovarian cancer
Naylor, M. S., Stamp, G. W., Davies, B. D., & Balkwill, F. R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580110 · Cited by 168
Montgomery, A. M. P., Mueller, B. M., Reisfeld, R., Taylor, S. M., & DeClerck, Y. A. (1994) · PubMed · Cited by 166
Visscher, D. W., Höyhtyä, M., Ottosen, S. K., Liang, C., Sarkar, F. H., Crissman, J. D., & Fridman, R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590308 · Cited by 162
Franchi, A., Santucci, M., Masini, E., Sardi, I., Paglierani, M., & Gallo, O. (2002) · Cancer · doi:10.1002/cncr.10916 · Cited by 160
Proteases in brain tumour progression
Levičar, N., Nutall, R. K., & Lah, T. T. (2003) · Acta Neurochirurgica · doi:10.1007/s00701-003-0097-z · Cited by 159
Expression of matrix metalloproteinases and their inhibitors in human brain tumors
Kachra, Z., Beaulieu, É., Delbecchi, L., Mousseau, N., Berthelet, F., Moumdjian, R. A., Maestro, R. F. D., & Béliveau, R. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006760632766 · Cited by 141
Väisänen, A., Kallioinen, M., Taskinen, P. J., & Turpeenniemi-Hujanen, T. (1998) · The Journal of Pathology · Cited by 134
Self-citationGohji, K., Fujimoto, N., Hara, I., Fujii, A., Gotoh, A., Okada, H., Arakawa, S., Kitazawa, S., Miyake, H., Kamidono, S., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980220)79:1<96::aid-ijc18>3.0.co;2-f · Cited by 134
Ranuncolo, S. M., Armanasco, E., Cresta, C., Joffé, E. B. D. K., & Puricelli, L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11288 · Cited by 127
Hendrix, M. J. C., Wood, W. R., Seftor, E. A., et al. (1990) · PubMed · Cited by 126
Stearns, M. E., Rhim, J. S., & Wang, M. (1999) · PubMed · Cited by 126
Clinical significance of determination of surrogate markers of angiogenesis in breast cancer
Gasparini, G. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00105-0 · Cited by 116
Herbst, R. S., Yano, S., Kuniyasu, H., Khuri, F. R., Bucana, C. D., Guo, F., Liu, D., Kemp, B. L., Lee, J. J., Hong, W. K., et al. (2000) · PubMed · Cited by 116
Bello, L., Lucini, V., Carrabba, G. G., Giussani, C. G., Machluf, M., Pluderi, M., Nikas, D. L., Zhang, J., Tomei, G., Villani, R. M., et al. (2001) · PubMed · Cited by 115
Davidson, B., Goldberg, I., Kopolovic, J., Lerner‐Geva, L., Gotlieb, W. H., Ben‐Baruch, G., & Reich, R. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5381 · Cited by 113
Leppä, S., Saarto, T. H., Vehmanen, L., BLOMQVIST, C. P., & Elomaa, I. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0047 · Cited by 103
Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer
Sivula, A., Talvensaari‐Mattila, A., Lundin, J. E., Joensuu, H., Haglund, C. H., Ristim�ki, A., & Turpeenniemi-Hujanen, T. M. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-0714-4 · Cited by 95
Self-citationPrognostic impact of matrix metalloproteinase‐9 in operable non‐small cell lung cancer
Sienel, W. G. R., Hellers, J., Morresi‐Hauf, A., Lichtinghagen, R., Mutschler, W., Jochum, M., Klein, C. A., Passlick, B., & Pantel, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10841 · Cited by 95
Ring, P., Johansson, K. A., Höyhtyä, M., Rubin, K., & Lindmark, G. E. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.466 · Cited by 93
Mohanam, S., Wang, S. W., Rayford, A., Yamamoto, M., Sawaya, R. A., Nakajima, M., Liotta, L. A., Nicolson, G. L., Stetler‐Stevenson, W. G., & Rao, J. S. (1995) · Clinical & Experimental Metastasis · doi:10.1007/bf00144019 · Cited by 93
Zhang, S. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i5.899 · Cited by 93
Amorino, G. P., & Hoover, R. L. (1998) · PubMed · Cited by 88
Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker inbladder cancer
Vasala, K., Pääkkö, P. K., & Turpeenniemi-Hujanen, T. M. (2003) · Urology · doi:10.1016/s0090-4295(03)00660-5 · Cited by 86
Self-citationJäälinoja, J., Herva, R., Korpela, M., Höyhtyä, M., & Turpeenniemi-Hujanen, T. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006421112839 · Cited by 82
Self-citationThorns, V., Walter, G. F., & Thorns, C. (2003) · PubMed · Cited by 76
Iurlaro, Loverro, G., Vacca, Cormio, G., Ribatti, Minischetti, Ria, R., Bruno, & Selvaggi, F. (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00532.x · Cited by 72
Davidson, B., Goldberg, I., Kopolovic, J., et al. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1998.5285 · Cited by 59
Hujanen, E., Väisänen, A., Zheng, A., Trygdvason, K., & Turpeenniemi-Hujanen, T. M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580422 · Cited by 57
Self-citationAljada, I. S., Ramnath, N., Donohue, K., Harvey, S. R., Brooks, J. J. S., Wiseman, S. M., Khoury, T., Loewen, G., Slocum, H. K., Anderson, T. M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.110 · Cited by 55
Pagenstecher, A., Wussler, E. M., Opdenakker, G., Volk, B., & Campbell, I. L. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.6.598 · Cited by 49
Stearns, M. E., Fudge, K., García, F., & Wang, M. (1997) · PubMed · Cited by 43
Takahashi, M., Fukami, S., Iwata, N., Inoue, K., Itohara, S., Itoh, H., Haraoka, J., & Saido, T. C. (2002) · Pharmacological Research · doi:10.1016/s1043-6618(02)00081-6 · Cited by 43
Young, T. N., Pizzo, S. V., & Stack, M. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.999 · Cited by 39
Nakopoulou, L., Katsarou, S., Giannopoulou, I., Alexandrou, P. T., Tsirmpa, I., Panayotopoulou, E. G., Mavrommatis, J., & Keramopoulos, A. (2002) · Modern Pathology · doi:10.1038/modpathol.3880486 · Cited by 36
Westerlund, A., Hujanen, E., Puistola, U., & Turpeenniemi-Hujanen, T. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4808 · Cited by 30
Self-citationWalther, M. M., Kleiner, D. E., Lubensky, I. A., Pozzatti, R., Nyguen, T., Gnarra, J. R., Hurley, K., Venzon, D. J., Linehan, W. M., & Stetler‐Stevenson, W. G. (1997) · Urology · doi:10.1016/s0090-4295(97)00220-3 · Cited by 26
Miyagi, E., Yasumitsu, H., Hirahara, F., Nagashima, Y., MINAGUCHI, H., Miyazaki, K., & Umeda, M. (1995) · Clinical & Experimental Metastasis · doi:10.1007/bf00133613 · Cited by 20
Lein, M., Nowak, L., Jung, K., et al. (1998) · Der Urologe · doi:10.1007/s001200050194 · Cited by 14
Cited by
Matrix metalloproteinases and tumor metastasis
Deryugina, E. I., & Quigley, J. P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7886-9 · Cited by 1,960
Vandooren, J., Van den Steen, P. E., & Opdenakker, G. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.770819 · Cited by 766
Bauvois, B. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.10.001 · Cited by 543
Assessment of Gelatinases (MMP-2 and MMP-9) by Gelatin Zymography
Toth, M., Sohail, A., & Fridman, R. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-854-2_8 · Cited by 395
Olson, E. S., Aguilera, T. A., Jiang, T., Ellies, L. G., Nguyen, Q. T., Wong, E. H., Gross, L. A., & Tsien, R. Y. (2009) · Integrative Biology · doi:10.1039/b904890a · Cited by 263
Metadata
- Authors
- Turpeenniemi-Hujanen, T.
- Venue
- Biochimie
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 87
- Issue
- 3-4
- Pages
- 287-297
- ISSN
- 0037-9042 (ISSN-L)
- 0300-9084
- OpenAlex
- W2041586000
- Cited by
- 289
- References
- 73
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.